The pharmaceutical and biotechnology sectors, which endured a protracted period of aggressive workforce contraction beginning in 2022, are beginning to…
Read More
As 59% fewer pharma companies cut staff in Q2 in 2026, job postings rise 15%
The biopharmaceutical landscape, which has been characterized by aggressive retrenchment and workforce volatility since 2022, is showing tentative signs of…
Read More
As 59% fewer pharma companies cut staff in Q2 in 2026, job postings rise 15%
The pharmaceutical and biotechnology sectors are showing tentative signs of stabilization as the aggressive downsizing trend that characterized the previous…
Read More
